Bottom line
What is PASRX's expense ratio?
PASRX's expense ratio is 1.23%, or about $123 a year on every $10,000 invested. That is more expensive than 75% of allocation / balanced funds we track (median 0.91%). It has no front-end sales load. Its expense ratio includes a 0.5% 12b-1 marketing fee.
Updated Jan 27, 2026
PASRX fee table
| Net expense ratio | 1.23% |
|---|---|
| Gross expense ratio | 1.23% |
| Management fee | 0.57% |
| 12b-1 (distribution) fee | 0.5% |
| Other expenses | 0.16% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Jan 27, 2026
What PASRX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| PASRX | $125 | $390 | $675 | $1,487 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.23% expense ratio costs roughly $66,800 in lost growth, versus about $50,800 for the median allocation / balanced fund (0.91%).
Cheaper alternatives to PASRX
These funds have a similar portfolio (by top-holdings overlap) and a lower expense ratio. Savings are per $10,000 invested.
*Difference in ending value of $10,000 after 20 years at a 6% gross annual return, net of each fund's expense ratio.